Latest News

US FTC settles case against anesthesia company

According to court documents filed Thursday, the U.S. Federal Trade Commission has settled a case it brought against a private-equity portfolio company that they claim was used to 'buy up anesthesiology practices and raise prices in Texas.

Why it's Important The FTC filed a lawsuit against U.S. Anesthesia Partners under the Biden Administration. This was a major antitrust move to combat private equity rollups or purchases of many small businesses, which allegedly reduce competition in an industry. Private equity firms will closely examine the terms of the settlement which has not yet been made public.

CONTEXT Under President Donald Trump, the FTC has prioritized healthcare. At the same time, it has stressed that it is prepared to settle on terms it deems 'adequate' to eliminate any problems. The FTC sued the private equity firm Welsh, Carson, Anderson & Stowe, who created USAP, but it settled after winning a bid against the claims.

BY THE NUMBERS According to the FTC, this rollup involved more than 12 anesthesiology clinics, 1,000 doctors and 750 nursing staff.

THE RESPONSE

The FTC stated that the settlement was?currently confidential 'to facilitate the USAP negotiations USAP must engage in.' However, the FTC also said that the deal "would restore a competitive market structure" and would be "consistent with longstanding FTC Settlement Best Practices." The FTC said that if USAP does not fully implement the settlement, it will resume its case.

USAP Chairman Scott Holliday stated in a press release that "it was vital to resolve this issue now in order for USAP to remain laser-focused in providing high-quality services." (Reporting from Jody Godoy, New York; editing by Rod Nickel and Paul Simao.)

(source: Reuters)